SPOTLIGHT -
March 13th 2023
The Future of Mental Health: Ketamine Therapy Report revealed that 55% of Americans who tried at home ketamine took more than the recommended dose.
December 8th 2022
Screening for the symptom of worthlessness could save your adolescent patient’s life…
October 30th 2022
The experts weighed in on a wide variety of psychiatric issues for the October 2022 issue of Psychiatric Times.
October 21st 2022
"Among adults living in the United States, 38% to 40% use complementary and alternative medicine therapies, yet only 42% have told their primary physician that they do so."
October 6th 2022
At-home ketamine treatment initiated by an online provider presents many legal, clinical, and ethical challenges...
The Week in Review: September 19-23
From historic USPSTF draft screening recommendations to the need for novel treatments for bipolar depression, here are highlights from the week in Psychiatric Times.
Read More
The Goldilocks Model for Assessing the New Anxiety Screening Recommendations
How can we increase assessment of anxiety without increasing other problems? Where is the balance?
USPSTF Makes Historic Anxiety and Depression Draft Screening Recommendations
For the first time, the USPSTF is recommending anxiety screening for adults under 65.
First Patient Dosed in Trial of LSD for Generalized Anxiety Disorder
The first patient has been dosed in the phase 2b dose-optimization trial of a pharmaceutically optimized form of LSD for the treatment of generalized anxiety disorder.
4 Ways to Help Immigrant and International College Students Deal With Acculturative Stress
With more immigrant students enrolling in US colleges, what can we do to help with their transition?
Complementary Effects of Combined Alternative Treatments on Social Anxiety Disorder
Treatments alter the neural processes underlying SAD symptoms.
Individuals Cite Exercise, Gaming as Top Ways to Address Mental Health Issues
The most common issues during the COVID-19 pandemic included stress, anxiety.
From the Pages of Psychiatric Times: February 2022
The experts weighed in on a wide variety of psychiatric issues for the Psychiatric Times February 2022 issue.
Defusing Catastrophe
Here’s how to help patients—and ourselves—recognize cognitive distortions.
Depression/Anxiety: Dimensional Treatment Decisions
Treatment decisions lie on a continuum—befitting a dimensional approach to diagnosis.
Why Use the DSM When It Is Inaccurate? Cognitive Biases and Solutions
Exploring cognitive biases toward the DSM and their avoidable effects on treatment decisions.
Higher Rates of Anxiety, Depression Reported Among Minority Children
Research also shows increased prevalence of social risks and unmet social needs.
ADHD and Generalized Anxiety Disorder: Hand in Hand?
Individuals with ADHD are 4 times more likely to have generalized anxiety disorder at some point in their life.
Helping Patients Thrive This Holiday Season
Are your patients feeling stressed out? Here are 10 tips to share with them for a less stressful holiday season.
My Life is Hell, Doc. Please Help Me!
Why are psychotherapeutic interventions crucial in the treatment of GAD and anxiety disorders in general?
The Unimaginable: Pregnancy and Infant Loss in Psychiatric Practice
Loss and suffering can be hard for both patient and provider. Here’s what we know, what we need to learn, and how to protect yourself as a clinician.
New Investigational Social Anxiety Disorder Drug Differentiates Mechanism of Action
PH94B for the treatment of social anxiety disorder further differentiates its mechanism of action from benzodiazepines in a new lab rat preclinical study.
The Cognitive Benefits of Matcha
A study compared matcha, a highly caffeinated green tea, to other sources of caffeine. Which had the greatest cognitive benefits?
I Had to Use
A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?
Anxiety Treatment at Your Fingertips
Key questions to consider when evaluating a digital therapeutic for anxiety.
Technology-Enabled Care: The Future of Our Field
What will psychiatric practice look like in the year 2030?
Mental Health in America: A Growing Crisis
What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.
Treating Psychiatric Combat Casualties
A working model for eliminating stigma and transforming mental healthcare within the military.
Reentry Anxiety
Why does the prospect of getting back to normal after the pandemic disturb some patients? And what can be done to overcome these fears?
What Is Resilience?
Resilience is a relatively neglected topic of research, but it has the power to dramatically improve patients' lives.
Trauma and the Politics of Diagnosis: Janice Haaken, PhD
How should the sociopolitical nature of PTSD as a diagnosis inform our understanding of trauma?
COVID-19 Blues
Research confirms COVID-19’s negative impact on Americans’ mental health.
Looking to the Future of MDMA-Assisted Psychotherapy
New research find altered states of consciousness may allow veterans and other patients with PTSD to face unspeakable experiences and find peace.
Psychiatry and the Long View: Paul Summergrad, MD
In this conversation, a former APA president discusses mystical and meditative experiences, reconciling psychoanalysis and neuroscience, and tensions surrounding the medical model.
Breaking the Skinny Standard: Anorexia on Screen
A television drama looks at eating disorders from the patient, physician, and family perspectives. What does it get right—and wrong?